Biodrug Delivery Systems (eBook, PDF)
Fundamentals, Applications and Clinical Development
Redaktion: Morishita, Mariko; Park, Kinam
81,95 €
81,95 €
inkl. MwSt.
Sofort per Download lieferbar
41 °P sammeln
81,95 €
Als Download kaufen
81,95 €
inkl. MwSt.
Sofort per Download lieferbar
41 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
81,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
41 °P sammeln
Biodrug Delivery Systems (eBook, PDF)
Fundamentals, Applications and Clinical Development
Redaktion: Morishita, Mariko; Park, Kinam
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
An international group of leading experts in drug development and biopharmaceutical science discusses the latest advances in biodrug delivery systems and associated techniques.
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 29.12MB
Andere Kunden interessierten sich auch für
- Vasant V. RanadeDrug Delivery Systems (eBook, PDF)250,95 €
- Bio-Targets and Drug Delivery Approaches (eBook, PDF)48,95 €
- Delivery Strategies for Antisense Oligonucleotide Therapeutics (eBook, PDF)59,95 €
- Ajay K BangaTransdermal and Intradermal Delivery of Therapeutic Agents (eBook, PDF)65,95 €
- Modified-Release Drug Delivery Technology (eBook, PDF)192,95 €
- Biomaterials for Delivery and Targeting of Proteins and Nucleic Acids (eBook, PDF)313,95 €
- Edward BauerPharmaceutical Packaging Handbook (eBook, PDF)188,95 €
-
-
-
An international group of leading experts in drug development and biopharmaceutical science discusses the latest advances in biodrug delivery systems and associated techniques.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 488
- Erscheinungstermin: 19. April 2016
- Englisch
- ISBN-13: 9781420086713
- Artikelnr.: 42051496
- Verlag: Taylor & Francis
- Seitenzahl: 488
- Erscheinungstermin: 19. April 2016
- Englisch
- ISBN-13: 9781420086713
- Artikelnr.: 42051496
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Mariko Morishita, Kinam Park
1. Overview of Biodrug delivery system. 2. Issues in Biodrug delivery
system. 3. Pharmacokinetic consideration of Biodrugs. Specific Route of
Delivery. 1. Parenteral delivery. 2. Brain delivery. 3. Ocular delivery. 4.
Nasal delivery. 5. Buccal delivery. 6. Pulmonary delivery. 7. Transdermal
delivery. 8. Colon delivery. 9. Oral delivery. 10. Cellular delivery.
Delivery Systems. 1. Targeting: PK consideration. Monoclonal antibody.
Receptor-mediated endocytosis. 2. Bioadhesive delivery system. 3. Modified
release delivery system. 4. Nanoparticulate delivery system. 5. Lipid-based
delivery system. 6. Implantable delivery system. 7. Modifying the
physiochemical nature of Biodrugs. 8. Regulatory perspective of Biodrug
development. Development of Biodrug Products. 1. Leuplin. 2. ANP (atrial
natriuretic peptide). 3. Amylin and GLP-1 agonists. 4. GHRP-2 (growth
hormone releasing peptide. 5. Endothelin receptor antagonist. 6.
Angiotensin II receptor antagonist. 7. Insulin (inhalation). 8. Calcitonin
(nasal, etc.). 9. Sandstatin LAR. 10. Interferon. 11. Vaccine. Perspective
of Biodrug Products.
system. 3. Pharmacokinetic consideration of Biodrugs. Specific Route of
Delivery. 1. Parenteral delivery. 2. Brain delivery. 3. Ocular delivery. 4.
Nasal delivery. 5. Buccal delivery. 6. Pulmonary delivery. 7. Transdermal
delivery. 8. Colon delivery. 9. Oral delivery. 10. Cellular delivery.
Delivery Systems. 1. Targeting: PK consideration. Monoclonal antibody.
Receptor-mediated endocytosis. 2. Bioadhesive delivery system. 3. Modified
release delivery system. 4. Nanoparticulate delivery system. 5. Lipid-based
delivery system. 6. Implantable delivery system. 7. Modifying the
physiochemical nature of Biodrugs. 8. Regulatory perspective of Biodrug
development. Development of Biodrug Products. 1. Leuplin. 2. ANP (atrial
natriuretic peptide). 3. Amylin and GLP-1 agonists. 4. GHRP-2 (growth
hormone releasing peptide. 5. Endothelin receptor antagonist. 6.
Angiotensin II receptor antagonist. 7. Insulin (inhalation). 8. Calcitonin
(nasal, etc.). 9. Sandstatin LAR. 10. Interferon. 11. Vaccine. Perspective
of Biodrug Products.
1. Overview of Biodrug delivery system. 2. Issues in Biodrug delivery
system. 3. Pharmacokinetic consideration of Biodrugs. Specific Route of
Delivery. 1. Parenteral delivery. 2. Brain delivery. 3. Ocular delivery. 4.
Nasal delivery. 5. Buccal delivery. 6. Pulmonary delivery. 7. Transdermal
delivery. 8. Colon delivery. 9. Oral delivery. 10. Cellular delivery.
Delivery Systems. 1. Targeting: PK consideration. Monoclonal antibody.
Receptor-mediated endocytosis. 2. Bioadhesive delivery system. 3. Modified
release delivery system. 4. Nanoparticulate delivery system. 5. Lipid-based
delivery system. 6. Implantable delivery system. 7. Modifying the
physiochemical nature of Biodrugs. 8. Regulatory perspective of Biodrug
development. Development of Biodrug Products. 1. Leuplin. 2. ANP (atrial
natriuretic peptide). 3. Amylin and GLP-1 agonists. 4. GHRP-2 (growth
hormone releasing peptide. 5. Endothelin receptor antagonist. 6.
Angiotensin II receptor antagonist. 7. Insulin (inhalation). 8. Calcitonin
(nasal, etc.). 9. Sandstatin LAR. 10. Interferon. 11. Vaccine. Perspective
of Biodrug Products.
system. 3. Pharmacokinetic consideration of Biodrugs. Specific Route of
Delivery. 1. Parenteral delivery. 2. Brain delivery. 3. Ocular delivery. 4.
Nasal delivery. 5. Buccal delivery. 6. Pulmonary delivery. 7. Transdermal
delivery. 8. Colon delivery. 9. Oral delivery. 10. Cellular delivery.
Delivery Systems. 1. Targeting: PK consideration. Monoclonal antibody.
Receptor-mediated endocytosis. 2. Bioadhesive delivery system. 3. Modified
release delivery system. 4. Nanoparticulate delivery system. 5. Lipid-based
delivery system. 6. Implantable delivery system. 7. Modifying the
physiochemical nature of Biodrugs. 8. Regulatory perspective of Biodrug
development. Development of Biodrug Products. 1. Leuplin. 2. ANP (atrial
natriuretic peptide). 3. Amylin and GLP-1 agonists. 4. GHRP-2 (growth
hormone releasing peptide. 5. Endothelin receptor antagonist. 6.
Angiotensin II receptor antagonist. 7. Insulin (inhalation). 8. Calcitonin
(nasal, etc.). 9. Sandstatin LAR. 10. Interferon. 11. Vaccine. Perspective
of Biodrug Products.